Education
About Us
Working with TipRanks
Follow Us
Oneview Healthcare PLC Chess Depository Interests repr 1 (AU:ONE)
ASX:ONE
ONE Stock Chart & Stats
AU$0.26
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.26
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.17 - AU$0.41
Previous CloseN/A
Volume4.96K
Average Volume (3M)344.03K
Market Cap
AU$164.95M
Enterprise ValueAU$98.76M
Total Cash (Recent Filing)AU$4.60M
Total Debt (Recent Filing)AU$1.99M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Sep 01, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding767,229,900
10 Day Avg. Volume303,620
30 Day Avg. Volume344,030
Financial Highlights & Ratios
PEG Ratio0.76
Price to Book (P/B)47.09
Price to Sales (P/S)14.39
P/FCF Ratio-20.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.45Price Target Upside73.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.01
Revenue Forecast (FY)AU$15.75M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Deployment MomentumSustained top‑line momentum and faster deployments indicate expanding product adoption and stronger commercial execution. A multi‑quarter trend of double‑digit revenue growth plus faster H2 deployments supports scale economics and recurring revenue expansion if conversion and upsell continue to execute.
Baxter GPO Partnership Expands Market AccessInclusion in a major GPO materially enlarges addressable market and lowers procurement friction for enterprise sales. A 156+ opportunity Baxter pipeline provides a structural commercial channel that can accelerate large deal access and lift long‑term ARR if conversion rates follow historical upsell patterns.
Product & AI Productivity Gains (SDLC)Meaningful engineering productivity gains reduce time‑to‑market and future development costs, supporting faster feature delivery and customer implementations. Structural SDLC improvements and AI tooling can sustain margin improvements and competitive differentiation over multiple quarters.
Bears Say
Persistent Cash Burn & LossesOperating losses and sustained negative cash flow show the business currently consumes capital faster than it generates it. Structural operating costs remain high relative to scale, increasing reliance on external financing and placing persistent pressure on the balance sheet until profitable operating leverage is achieved.
Modest Cash Balance / Limited RunwayA small year‑end cash balance versus significant recurring cash burn creates a tangible short‑term financing need. Even with announced OpEx savings, modest cash reserves reduce optionality and raise execution risk over the coming quarters absent reliable funding or rapid margin improvement.
Long Sales Cycles & Conversion RiskHeavy reliance on long enterprise sales and upsell to realize addressable opportunity creates structural timing uncertainty for revenue recognition. Regulatory/capital spending variability and multi‑year procurement cycles make scaling revenue and reaching positive cash flow dependent on slow, uncertain conversion outcomes.
Oneview Healthcare Chess Depository Interests repr 1 News
ONE FAQ
What was Oneview Healthcare PLC Chess Depository Interests repr 1’s price range in the past 12 months?
Oneview Healthcare PLC Chess Depository Interests repr 1 lowest share price was AU$0.17 and its highest was AU$0.41 in the past 12 months.
What is Oneview Healthcare PLC Chess Depository Interests repr 1’s market cap?
Oneview Healthcare PLC Chess Depository Interests repr 1’s market cap is AU$164.95M.
When is Oneview Healthcare PLC Chess Depository Interests repr 1’s upcoming earnings report date?
Oneview Healthcare PLC Chess Depository Interests repr 1’s upcoming earnings report date is Sep 01, 2026 which is in 167 days.
How were Oneview Healthcare PLC Chess Depository Interests repr 1’s earnings last quarter?
Oneview Healthcare PLC Chess Depository Interests repr 1 released its earnings results on Feb 11, 2026. The company reported -AU$0.01 earnings per share for the quarter, beating the consensus estimate of -AU$0.012 by AU$0.002.
Is Oneview Healthcare PLC Chess Depository Interests repr 1 overvalued?
According to Wall Street analysts Oneview Healthcare PLC Chess Depository Interests repr 1’s price is currently Undervalued.
Does Oneview Healthcare PLC Chess Depository Interests repr 1 pay dividends?
Oneview Healthcare PLC Chess Depository Interests repr 1 does not currently pay dividends.
What is Oneview Healthcare PLC Chess Depository Interests repr 1’s EPS estimate?
Oneview Healthcare PLC Chess Depository Interests repr 1’s EPS estimate is -0.01.
How many shares outstanding does Oneview Healthcare PLC Chess Depository Interests repr 1 have?
Oneview Healthcare PLC Chess Depository Interests repr 1 has 767,229,900 shares outstanding.
What happened to Oneview Healthcare PLC Chess Depository Interests repr 1’s price movement after its last earnings report?
Oneview Healthcare PLC Chess Depository Interests repr 1 reported an EPS of -AU$0.01 in its last earnings report, beating expectations of -AU$0.012. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of Oneview Healthcare PLC Chess Depository Interests repr 1?
Currently, no hedge funds are holding shares in AU:ONE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oneview Healthcare Chess Depository Interests repr 1 Stock Smart Score
Company Description
Oneview Healthcare PLC Chess Depository Interests repr 1
Oneview Healthcare Chess Depository Interests repr 1 (ONE) is a healthcare technology company that focuses on providing innovative digital solutions to enhance patient and operational outcomes in the healthcare sector. The company primarily offers a digital patient engagement platform that streamlines communication between healthcare providers and patients, facilitates data sharing, and improves overall patient experience. Oneview Healthcare operates within the broader healthcare technology industry, catering to hospitals, clinics, and other healthcare organizations seeking to modernize their patient care processes.
Oneview Healthcare Chess Depository Interests repr 1 (ONE) Earnings & Revenues
ONE Company Deck
ONE Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicates strong commercial momentum and meaningful progress on product innovation and AI‑driven productivity—highlighted by 21% reported revenue growth (25%+ constant currency), accelerated deployments, a major Baxter partnership and clear cost‑efficiency gains (H2 OpEx down and >EUR 1.4m annualized run‑rate savings). However, material challenges remain: the company is still operating at an EBITDA loss (EUR 8.1m), cash is modest (EUR 4.6m), gross margin was compressed by revenue mix and conversion of a large Baxter/GPO pipeline and enterprise expansions are uncertain and subject to lengthy sales cycles and regulatory/capital‑spending risks. On balance, the positives (growth, partnerships, product/AI progress and OpEx improvement) outweigh the negatives, but execution and pipeline conversion will be critical to sustain the trajectory.View all AU:ONE earnings summariesONE Stock 12 Month Forecast
Average Price Target
AU$0.45
▲(73.08% Upside)
Technical Analysis
Cogstate Ltd
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―
PainChek Ltd
―
Options Prices
Currently, No data available
---